-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B05d27UalkTOuLBeGzV0yrbo6c+tn21D+h+opoqXO80vRtbTdpVeU8OByUd/nv2n 9PXtiYfcmBLJoUNzRD/x5g== 0001299933-04-001040.txt : 20041006 0001299933-04-001040.hdr.sgml : 20041006 20041006110029 ACCESSION NUMBER: 0001299933-04-001040 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20041006 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20041006 DATE AS OF CHANGE: 20041006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MERCK & CO INC CENTRAL INDEX KEY: 0000064978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221109110 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03305 FILM NUMBER: 041067495 BUSINESS ADDRESS: STREET 1: ONE MERCK DR STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 9084234044 MAIL ADDRESS: STREET 1: ONE MERCK DR STREET 2: PO BOX 100 WS3AB-05 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 8-K 1 htm_1110.htm LIVE FILING Merck & Co., Inc. (Form: 8-K)  

 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   October 6, 2004

Merck & Co., Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

         
New Jersey   1-3305   22-1109110
_____________________
(State or other jurisdiction
  _____________
(Commission
  ______________
(I.R.S. Employer
of incorporation)   File Number)   Identification No.)
          
One Merck Drive, P.O. Box 100, Whitehouse Station, NJ       08889
_________________________________
(Address of principal executive offices)
      ___________
(Zip Code)
     
Registrant’s telephone number, including area code   908-423-1000

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 8.01. Other Events.

Incorporated by reference is a press release issued by the Registrant on October 6, 2004, attached as Exhibit 99, announcing the election of Rochelle B. Lazarus to the Registrant's Board of Directors, effective October 26, 2004.





Item 9.01. Financial Statements and Exhibits.

(c) Exhibits

Exhibit 99 - Press Release issued October 6, 2004






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Merck & Co., Inc.
(Registrant)
          
October 6, 2004   By:   /s/ Debra A. Bollwage
       
        Name: /s/ Debra A. Bollwage
        Title: Assistant Secretary


Exhibit Index


     
Exhibit No.   Description

 
EX-99
  Press Release issued October 6, 2004
EX-99 2 exhibit1.htm EX-99 EX-99

Exhibit 99

News Release

   

             
Media Contacts:
  Anita Larsen
(908) 423-6022
  Investor Contact:   Michael Rabinowitz
(908) 423-5185
 
           
 
  Chris Loder
(908) 423-3786
 

 

Ogilvy & Mather’s Shelly Lazarus Elected to Merck Board of Directors

WHITEHOUSE STATION, N.J., Oct. 6, 2004 – Merck & Co., Inc. today announced that Shelly Lazarus, 57, chairman and chief executive officer of Ogilvy & Mather Worldwide, one of the world’s leading advertising and marketing communication companies, will join the company’s Board of Directors effective Oct. 26. With her election, Ms. Lazarus will become one of 11 outside directors on the 12-member board. Ms. Lazarus will stand for election by the company’s stockholders in April 2005.

Ranked by Fortune magazine as one of the “50 Most Powerful Women in Business” each year since the list’s inception in 1998, Ms. Lazarus has spent more than three decades building such top advertising brands as American Express, IBM, Maxwell House and Dove. Ms. Lazarus first joined Ogilvy & Mather in the early 1970s, serving on many of the company’s signature accounts before taking a key role as the head of the company’s North American direct marketing unit. From there she moved back into general advertising and rose steadily, becoming president of the company’s flagship New York office in 1991, then head of Ogilvy & Mather North America in 1994. In 1995, she was named president and chief operating officer of Ogilvy & Mather Worldwide. Ms. Lazarus was named CEO in 1996, and was made chairman the following year.

A graduate of Smith College, Ms. Lazarus earned her M.B.A. in marketing from Columbia University in 1970. Most recently, she received Columbia Business School’s Distinguished Leadership Award in Business – the first woman to receive the honor.

Ms. Lazarus serves on a number of boards, including General Electric, New York Presbyterian Hospital, American Museum of Natural History, World Wildlife Fund and the Board of Overseers of the Columbia Business School. She is a member of the Council on Foreign Relations and the Business Council. She was Chairman of the Board of Trustees for Smith College, and was Chairman of the American Association of Advertising Agencies, one of only two women to hold that position.

- more –

- 2 –

Ms. Lazarus is married to George Lazarus, a pediatrician in Manhattan. They have three children.

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company. Merck discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly or through its joint ventures.

# # #

-----END PRIVACY-ENHANCED MESSAGE-----